Filters
Race, sex, preterm status predict childhood adipokine trajectory
Factors such as preterm status, race, and biological sex are significantly associated with adipokine trajectory throughout childhood, as shown in a study.
Hot flashes are no small matter. Get it treated to improve your quality of life.
Professor Dr Nazimah Idris, professor of obstetrics and gynaecology and medical director at IMU Healthcare, touches on the topic of menopause and perimenopause.
Fighting obesity requires all the help one can get.
A swallowable balloon is now available to help obese people lose weight.
Simvastatin plus beta blocker improves survival of cirrhotic patients with variceal bleeding
The addition of simvastatin to a nonselective beta blocker results in better survival among cirrhotic patients with variceal bleeding, reports a study presented at EASL 2023.
Ketogenic diet reduces weight, raises aldosterone
Adherence to ketogenic diets (KDs) results in weight reduction and increased aldosterone concentrations without worsening cardiometabolic risk factors, suggests a study.
Oral health screening holds potential for diabetes prevention
Basic indicators of oral health appear to be associated with the risk of developing diabetes, according to a study, suggesting the importance of oral health screening for preventing diabetes.
Tirzepatide induces weight loss in overweight/obese patients with T2D
Treatment with once-weekly tirzepatide, a GIP* and GLP-1** receptor agonist, led to a substantial weight reduction among overweight or obese adults with type 2 diabetes (T2D), according to the phase III SURMOUNT-2 trial presented at ADA 2023.
Tirzepatide bests placebo, other glucose-lowering drugs at keeping lipid levels, waistline in check
Treatment with tirzepatide is associated with better lipid profile and waist circumference outcomes compared with placebo and other glucose-lowering drugs, according to a study.
Baseline HbA1c strongly predicts metformin failure
Baseline glycated haemoglobin (HbA1c) is the most robust risk factor for metformin failure, reveals a study, noting that routinely available clinical data may be used to identify high-risk patients who may benefit from closer monitoring and earlier treatment intensification.
Anti-obesity therapies go beyond weight loss
Weight loss strategies do not only provide therapeutic alternatives for obesity but may also hold promise in the management of type 2 diabetes (T2D) and NAFLD*.
